Insight journal - Company

Merck KGaA: Partnering activity 2005-2013

Posted on 09 July 2013

Tags: , , , ,

Merck KGaA and Merck Serono announced over 136 partnering / licensing deals since 2005, with 28 deals in 2007 alone. Analysis of the partnering deals shows a strong emphasis on partnerships in oncology.

Abstracted from: Partnering Agreements with Merck KGaA/ Merck Serono 2005-2013

The number of partnering, collaborative R&D and licensing deals announced varied year on year with a peak of 18 deals announced in 2008, after which partnering activity slowed down to an average of 10 deals in the past 4 years.

The following figure shows the level of Merck KGaA partnering deal announcements since 2005.

Figure 1: Merck KGaA/ Merck Serono partnering deals 2005-2013

Merck KgaA partnering by year

Source: Current Agreements, 2013

Further analysis of these deals shows that Merck KGaA/ Merck Serono has a preference for collaborative R&D and licensing deals, similar to many other top pharmaceutical or big pharma companies. Such partnering deals provide the right for Merck KGaA to exploit the licensors technology in return for payment of upfront, development and sales, and royalty payments.

The following table provides an overview of the partnering deals announced by Merck KGaA/ Merck Serono based on deal type disclosed.

Figure 2: Merck KGaA/ Merck Serono partnering deals by deal type 2005-2013

Merck kgaA partnering by deal type

Source: Current Agreements, 2013

When looking at stage of development for Merck KGaA and Merck Serono, at partnering deal signing, the most popular stage at signing is discovery with 56 deal announcements, followed by preclinical and marketed stage with 28 and 19 deal announcements, respectively.

Merck KGaA and Merck Serono is also active in partnering at phase I, phase II and phase III stage deals. Such deals are of on-going importance to all top pharmaceutical companies as they seek to bolster their pipeline, fill gaps left as a result of drug candidates failing during clinical development, and ensure they have replacement products for when key drugs come off patent.

The following table provides an overview of the partnering deals announced by Merck KGaA/ Merck Serono based on stage of development at signature.

Figure 3: Merck KGaA/ Merck Serono partnering by stage of development 2005-2013

Merck KgaA partnering by stage of development

Source: Current Agreements, 2013

Merck KGaA/Merck Serono has signed over 166 partnering, collaborative R&D and licensing deals since 2005. The following provides a summary of the top deals by headline value.

Figure 5: Top Merck KGaA/ Merck Serono partnering deals by headline value 2005-2013

Merck KgaA top partnering deals by value

Source: Current Agreements, 2013

Our report provides more detailed insight into the details of each deal. See: Partnering Agreements with Merck KGaA / Merck Serono 2005-2013

Merck KGaA/ Merck Serono at Current Agreements                

View all M&A deals for Merck KGaA/ Serono:  2013 | 2012 | 2011 2010 | 2009 | 2008 | 2007 | 2006 | 2005

Full details on each deal can be found at CurrentAgreements (subscription required)

Or purchase report: Partnering Agreements with Merck KGaA / Merck Serono 2005-2013 

More

Summary profile data for Merck KgaA / Merck Serono

Partnering interests for Merck KgaA / Merck Serono

M&A activity for Merck KgaA / Merck Serono

 

Available reports from Current Partnering

Report: Partnering Deals and Alliances with Merck KgaA / Merck Serono

Report: Partnering Deals and Alliances with Big Pharma

 

Available resources for deal coverage for Merck KgaA / Merck Serono

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Read: more on Merck KgaA / Merck Serono company profile, recent partnering, M&A and financing news and articles

 

Related

Report: Practical Guide to Finding Partners

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s M&A Scorecard – view top life science M&A deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk

View: Top 50 biotech – overview of top 50 biotechnology companies by revenue – partnering activity, deal news, partnering dealtalk

Print Friendly, PDF & Email

Leave a Reply